Qureshi Adnan I, Saleem Muhammad A, Aytaç Emrah, Malik Ahmed A
Zeenat Qureshi Stroke Research Institute, St. Cloud, MN, USA.
J Vasc Interv Neurol. 2017 Jan;9(3):45-50.
The risk of catheter-based angiograms alone (non-therapeutic angiogram that does not lead to therapeutic intervention) in acute ischemic stroke patients who are considered for endovascular treatment is not well studied.
We compared the rates of neurological deterioration within 24 h; symptomatic intracranial hemorrhage (ICH) within 30 h; acute kidney injury (AKI) and major non-ICH within five days; and functional independence (defined by modified Rankin scale of 0-2) at three months among subjects who underwent a non-therapeutic catheter-based angiogram with subjects who did not undergo catheter-based angiogram in a multicenter clinical trial. Logistic regression analyses was performed to adjust for age, baseline Alberta stroke program early CT score (ASPECTS) strata (0-7 and 8-10), and baseline National Institutes of Health Stroke Scale (NIHSS) score strata (≤9, 10-19, and ≥20).
Compared with subjects who did not undergo any catheter-based angiogram ( = 222), 89 subjects who underwent a non-therapeutic catheter-based angiogram had similar adjusted rates of neurological deterioration [odds ratio (OR) = 1; 95% confidence interval (CI) 0.4-2.3; p = 1] and symptomatic ICH (OR = 0.4; 95% CI 0.1-1.8; = 0.2). There was no difference in the adjusted rates of AKI, or non-ICH between the two groups. The rate of functional independence at three months was significantly higher among the patients who received a catheter-based angiogram (OR = 2; 95% CI 1.1-3.5; = 0.016) after adjusting for potential confounders.
Non-therapeutic catheter-based angiograms in acute ischemic stroke patients who are being considered for endovascular treatment do not adversely affect patient outcomes.
对于考虑进行血管内治疗的急性缺血性卒中患者,仅进行基于导管的血管造影(不导致治疗干预的非治疗性血管造影)的风险尚未得到充分研究。
在一项多中心临床试验中,我们比较了接受非治疗性基于导管的血管造影的受试者与未接受基于导管的血管造影的受试者在24小时内神经功能恶化的发生率;30小时内症状性颅内出血(ICH)的发生率;五天内急性肾损伤(AKI)和主要非ICH的发生率;以及三个月时的功能独立性(根据改良Rankin量表0-2定义)。进行逻辑回归分析以调整年龄、基线艾伯塔卒中项目早期CT评分(ASPECTS)分层(0-7和8-10)以及基线美国国立卫生研究院卒中量表(NIHSS)评分分层(≤9、10-19和≥20)。
与未接受任何基于导管的血管造影的受试者(n = 222)相比,89名接受非治疗性基于导管的血管造影的受试者在调整后的神经功能恶化发生率[优势比(OR)= 1;95%置信区间(CI)0.4-2.3;p = 1]和症状性ICH发生率(OR = 0.4;95% CI 0.1-1.8;p = 0.2)相似。两组在调整后的AKI或非ICH发生率上没有差异。在调整潜在混杂因素后,接受基于导管的血管造影的患者在三个月时的功能独立性发生率显著更高(OR = 2;95% CI 1.1-3.5;p = 0.016)。
对于考虑进行血管内治疗的急性缺血性卒中患者,非治疗性基于导管的血管造影不会对患者预后产生不利影响。